{"id":36355,"date":"2025-12-17T14:27:19","date_gmt":"2025-12-17T22:27:19","guid":{"rendered":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options-copy"},"modified":"2025-12-17T14:33:07","modified_gmt":"2025-12-17T22:33:07","slug":"how-to-get-retatrutide-in-2026-understanding-your-options","status":"publish","type":"post","link":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options","title":{"rendered":"How to Get Retatrutide in 2026: Understanding Your Options"},"content":{"rendered":"<div class=\"dad65929\">\n<div class=\"_4f9bf79 d7dc56a8 _43c05b5\">\n<div class=\"ds-message _63c77b1\">\n<div class=\"ds-markdown\">\n<p class=\"ds-markdown-paragraph\"><a href=\"https:\/\/getheally.com\/patients\/weight-loss-info\/what-is-retatrutide\">Retatrutide<\/a> is a promising &#8220;<a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12304053\/\">triple agonist<\/a>&#8221; weight loss medication that has shown impressive results in clinical trials. However, it is not currently FDA-approved for any condition and is expected to remain in the investigational phase for the near future. So far, as of late 2025, its manufacturer, Eli Lilly, has seven additional Phase III clinical trials <a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/lilly-retatrutide-data-phase-iii-trial\/\">expected to conclude in 2026<\/a>. While widespread patient access is not anticipated until a potential FDA approval in 2026 or later, there are structured pathways to access investigational drugs before they reach the market.<\/p>\n<h2 id=\"can-you-access-retatrutide-before-full-approval\">Can You Access Retatrutide Before Full Approval?<\/h2>\n<p class=\"ds-markdown-paragraph\">Currently,\u00a0direct access to Retatrutide <a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\">before FDA approval is extremely limited<\/a> and typically not available to the general public.\u00a0It is <a href=\"https:\/\/onthepen.substack.com\/p\/retatrutide-still-a-year-away-the\">not legally available<\/a> for individual prescription at standard or compounding pharmacies.<\/p>\n<p class=\"ds-markdown-paragraph\">The table below summarizes the only legitimate ways to access Retatrutide before it is commercially available.<\/p>\n<div class=\"ds-scroll-area _1210dd7 c03cafe9\">\n<table>\n<thead>\n<tr>\n<th>Pathway<\/th>\n<th>Description<\/th>\n<th>Current Status for Retatrutide (Late 2025)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Clinical Trials<\/td>\n<td>Participation in official research studies conducted by Eli Lilly.<\/td>\n<td>Available.\u00a0This is the primary legal access point. Multiple <a href=\"https:\/\/www.clinicaltrialsarena.com\/news\/lilly-retatrutide-data-phase-iii-trial\/\">active Phase III trials are ongoing<\/a>.<\/td>\n<\/tr>\n<tr>\n<td>Compassionate Use \/ Expanded Access<\/td>\n<td>A program for patients with serious conditions and no other treatment options.<\/td>\n<td>Not currently available.\u00a0As of May 2025, no public expanded access program was active for Retatrutide.<\/td>\n<\/tr>\n<tr>\n<td>Legal Compounding<\/td>\n<td>Custom medication prepared by a licensed pharmacy for an individual patient.<\/td>\n<td><a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\">Explicitly prohibited<\/a>.\u00a0The FDA states Retatrutide is not a component of any FDA-approved drug and &#8220;cannot be used in compounding under federal law&#8221;.<\/td>\n<\/tr>\n<tr>\n<td>Commercial or &#8220;Gray Market&#8221;<\/td>\n<td>Products sold online by unregulated suppliers, often labeled &#8220;for research&#8221; or &#8220;not for human consumption.&#8221;<\/td>\n<td>Illegal and dangerous.\u00a0The <a href=\"https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/warning-letters\/glp-1-solution-09092025\">FDA has issued warning letters<\/a> to companies illegally selling unapproved Retatrutide.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2 id=\"enrolling-in-clinical-trials\">Enrolling in Clinical Trials<\/h2>\n<p class=\"ds-markdown-paragraph\">Clinical trials are the\u00a0only recommended and legal way\u00a0to try Retatrutide today. Eli Lilly is conducting a comprehensive Phase III program, with trials studying the drug for obesity and related conditions like knee osteoarthritis.<\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Where to Find Them:\u00a0The U.S. National Library of Medicine maintains\u00a0<a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">ClinicalTrials.gov<\/a>, a searchable database of all ongoing studies. You can search for &#8220;retatrutide&#8221; to find actively recruiting trials.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Eligibility and Application:\u00a0Each trial has strict inclusion and exclusion criteria (e.g., specific BMI, medical history, age). You cannot apply directly; you must express interest through the study sites listed, which will evaluate your eligibility.<\/p>\n<\/li>\n<\/ul>\n<h2 id=\"compassionate-use-programs\">Compassionate Use Programs<\/h2>\n<p class=\"ds-markdown-paragraph\">Compassionate use (or expanded access) is a regulatory pathway that allows the use of an investigational drug\u00a0outside of a clinical trial\u00a0for patients with a serious or immediately life-threatening condition who have no comparable treatment options. The goal is primarily\u00a0therapeutic, not experimental. For Retatrutide, this pathway is not currently active, meaning the manufacturer is not accepting requests, likely because the drug is still being tested in broader clinical populations.<\/p>\n<h2 id=\"are-there-legal-or-ethical-concerns-with-early-access\">Are There Legal or Ethical Concerns with Early Access?<\/h2>\n<p class=\"ds-markdown-paragraph\">Pursuing illegal early access carries significant risks. The FDA has issued strong warnings about unapproved weight loss drugs.<\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Safety and Quality Risks:\u00a0Products sold outside regulated channels are of\u00a0unknown quality and purity. They may contain incorrect doses, different ingredients (like unstudied salt forms), contaminants, or no active drug at all.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Legal Risks:\u00a0Selling and distributing unapproved versions of Retatrutide is illegal. The FDA has taken enforcement action, including warning letters and seizures, against companies engaged in this activity.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Ethical and Market Impact:\u00a0Widespread &#8220;gray market&#8221; use can complicate clinical trial recruitment and may create inaccurate perceptions of the drug&#8217;s real-world safety and efficacy before it is fully studied.<\/p>\n<\/li>\n<\/ul>\n<h2 id=\"should-you-wait-or-try-to-access-it-now\">Should You Wait or Try to Access It Now?<\/h2>\n<h3 id=\"should-you-wait-or-try-to-access-retatrutide-now\"><strong>Should You Wait or Try to Access Retatrutide Now?<\/strong><\/h3>\n<p class=\"ds-markdown-paragraph\">So, should you consider trying to get it now, or is waiting the better move?\u00a0<strong>Really, it comes down to<\/strong>\u00a0your personal health picture and how much uncertainty you\u2019re comfortable with.<\/p>\n<p class=\"ds-markdown-paragraph\"><strong>You might be a good fit for a clinical trial if:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">You meet typical enrollment criteria (like having obesity or overweight with a related health condition),\u00a0<strong>and<\/strong><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">You\u2019re open to the unknowns of an investigational treatment\u2014<strong>including<\/strong>\u00a0potential side effects and the chance of receiving a placebo.<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>On the other hand, waiting for FDA approval is likely your best and safest choice if:<\/strong><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">You don\u2019t qualify for or can\u2019t find a suitable trial.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">This way, you can be confident you&#8217;re receiving a product that&#8217;s been fully vetted for safety, strength, and quality.<\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><strong>While you wait,<\/strong>\u00a0a practical step is to talk to your doctor about currently approved medications, such as tirzepatide (Zepbound) or semaglutide (Wegovy).<\/p>\n<h2 id=\"other-weight-loss-options\">Other Weight Loss Options<\/h2>\n<h4 id=\"active-ingredient-semaglutide\" data-start=\"89\" data-end=\"127\">Active Ingredient: Semaglutide<\/h4>\n<p><a href=\"https:\/\/getheally.com\/patients\/semaglutide\">Semaglutide<\/a> is a <strong>GLP-1 receptor agonist only<\/strong>. It mimics the hormone GLP-1, which helps regulate blood sugar and appetite.<\/p>\n<div class=\"_tableContainer_16hzy_1\">\n<div class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"129\" data-end=\"890\">\n<thead data-start=\"129\" data-end=\"278\">\n<tr data-start=\"129\" data-end=\"278\">\n<th data-start=\"129\" data-end=\"146\" data-col-size=\"sm\">Brand Name<\/th>\n<th data-start=\"146\" data-end=\"165\" data-col-size=\"sm\">Manufacturer<\/th>\n<th data-start=\"165\" data-end=\"191\" data-col-size=\"sm\">Route<\/th>\n<th data-start=\"191\" data-end=\"253\" data-col-size=\"md\">FDA-Approved Use<\/th>\n<th data-start=\"253\" data-end=\"278\" data-col-size=\"sm\">FDA Approval Year<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"432\" data-end=\"890\">\n<tr data-start=\"432\" data-end=\"584\">\n<td data-start=\"432\" data-end=\"449\" data-col-size=\"sm\"><a href=\"https:\/\/getheally.com\/patients\/ozempic\">Ozempic<\/a><\/td>\n<td data-col-size=\"sm\" data-start=\"449\" data-end=\"468\">Novo Nordisk<\/td>\n<td data-col-size=\"sm\" data-start=\"468\" data-end=\"495\">Injectable (weekly)<\/td>\n<td data-col-size=\"md\" data-start=\"495\" data-end=\"558\">Type 2 diabetes; Cardiovascular risk reduction<\/td>\n<td data-col-size=\"sm\" data-start=\"558\" data-end=\"584\">2017<\/td>\n<\/tr>\n<tr data-start=\"585\" data-end=\"737\">\n<td data-start=\"585\" data-end=\"602\" data-col-size=\"sm\"><a href=\"https:\/\/getheally.com\/patients\/wegovy\">Wegovy<\/a><\/td>\n<td data-col-size=\"sm\" data-start=\"602\" data-end=\"621\">Novo Nordisk<\/td>\n<td data-col-size=\"sm\" data-start=\"621\" data-end=\"648\">Injectable (weekly)<\/td>\n<td data-col-size=\"md\" data-start=\"648\" data-end=\"711\">Chronic weight management<\/td>\n<td data-col-size=\"sm\" data-start=\"711\" data-end=\"737\">2021<\/td>\n<\/tr>\n<tr data-start=\"738\" data-end=\"890\">\n<td data-start=\"738\" data-end=\"755\" data-col-size=\"sm\"><a href=\"https:\/\/getheally.com\/patients\/rybelsus\">Rybelsus<\/a><\/td>\n<td data-col-size=\"sm\" data-start=\"755\" data-end=\"774\">Novo Nordisk<\/td>\n<td data-col-size=\"sm\" data-start=\"774\" data-end=\"801\">Oral (daily tablet)<\/td>\n<td data-col-size=\"md\" data-start=\"801\" data-end=\"864\">Type 2 diabetes<\/td>\n<td data-col-size=\"sm\" data-start=\"864\" data-end=\"890\">2019<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"absolute end-0 flex items-end\">Throughout this article, any reference to semaglutide for weight loss refers to Wegovy. Mentions of semaglutide for blood sugar control refer to Ozempic.<\/div>\n<\/div>\n<\/div>\n<div class=\"_tableContainer_16hzy_1\">\n<div class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\">\n<h4 id=\"active-ingredient-tirzepatide\">Active Ingredient: Tirzepatide<\/h4>\n<p><a href=\"https:\/\/getheally.com\/patients\/tirzepatide\">Tirzepatide<\/a> is a <strong>dual agonist \u2014 it activates GLP-1 receptors <em>and<\/em> GIP (glucose-dependent insulinotropic polypeptide) receptors<\/strong>. The added GIP activity may enhance weight loss and blood sugar control compared to GLP-1\u2013only drugs.<\/p>\n<div class=\"_tableContainer_16hzy_1\">\n<div class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\">\n<table class=\"w-fit min-w-(--thread-content-width)\">\n<thead>\n<tr>\n<th data-col-size=\"sm\">Brand Name<\/th>\n<th data-col-size=\"sm\">Manufacturer<\/th>\n<th data-col-size=\"sm\">Route<\/th>\n<th data-col-size=\"sm\">FDA-Approved Use<\/th>\n<th data-col-size=\"sm\">FDA Approval Year<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td data-col-size=\"sm\"><a href=\"https:\/\/getheally.com\/patients\/mounjaro\">Mounjaro<\/a><\/td>\n<td data-col-size=\"sm\">Eli Lilly<\/td>\n<td data-col-size=\"sm\">Injectable (weekly)<\/td>\n<td data-col-size=\"sm\">Type 2 diabetes<\/td>\n<td data-col-size=\"sm\">2022<\/td>\n<\/tr>\n<tr>\n<td data-col-size=\"sm\"><a href=\"https:\/\/getheally.com\/patients\/zepbound\">Zepbound<\/a><\/td>\n<td data-col-size=\"sm\">Eli Lilly<\/td>\n<td data-col-size=\"sm\">Injectable (weekly)<\/td>\n<td data-col-size=\"sm\">Chronic weight management, Obstructive Sleep Apnea<\/td>\n<td data-col-size=\"sm\">2023<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"absolute end-0 flex items-end\">Throughout this article, any reference to Tirzepatide for weight loss refers to Zepbound. Mentions of Tirzepatide for blood sugar control refer to Mounjaro.<\/div>\n<\/div>\n<\/div>\n<h4 id=\"active-ingredient-retatrutide\" data-start=\"153\" data-end=\"187\">Active Ingredient: Retatrutide<\/h4>\n<p data-start=\"189\" data-end=\"360\">Retatrutide is an experimental <strong>triple receptor agonist\u2014activating GLP-1, GIP, and glucagon receptors<\/strong>\u2014designed to enhance weight loss and metabolic control.<\/p>\n<div class=\"_tableContainer_16hzy_1\">\n<div class=\"_tableWrapper_16hzy_14 group flex w-fit flex-col-reverse\">\n<table class=\"w-fit min-w-(--thread-content-width)\" data-start=\"362\" data-end=\"772\">\n<thead data-start=\"362\" data-end=\"496\">\n<tr data-start=\"362\" data-end=\"496\">\n<th data-start=\"362\" data-end=\"379\" data-col-size=\"sm\">Brand Name<\/th>\n<th data-start=\"379\" data-end=\"402\" data-col-size=\"sm\">Manufacturer<\/th>\n<th data-start=\"402\" data-end=\"427\" data-col-size=\"sm\">Route<\/th>\n<th data-start=\"427\" data-end=\"471\" data-col-size=\"md\">Potential FDA-Approved Use<\/th>\n<th data-start=\"471\" data-end=\"496\" data-col-size=\"sm\">FDA Approval Year<\/th>\n<\/tr>\n<\/thead>\n<tbody data-start=\"634\" data-end=\"772\">\n<tr data-start=\"634\" data-end=\"772\">\n<td data-start=\"634\" data-end=\"651\" data-col-size=\"sm\">\u2014<\/td>\n<td data-start=\"651\" data-end=\"675\" data-col-size=\"sm\">Eli Lilly and Company<\/td>\n<td data-start=\"675\" data-end=\"700\" data-col-size=\"sm\">Injectable (weekly)<\/td>\n<td data-start=\"700\" data-end=\"746\" data-col-size=\"md\">Investigational use for obesity, type 2 diabetes, nonalcoholic fatty liver disease, Obstructive Sleep Apnea, Osteoarthritis Pain Relief<\/td>\n<td data-col-size=\"sm\" data-start=\"746\" data-end=\"772\">Not yet approved (In clinical trials Phase III)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"sticky end-(--thread-content-margin) h-0 self-end select-none\">\n<div class=\"absolute end-0 flex items-end\">Throughout this article, note that Retatrutide is not yet FDA-approved\u2014it remains investigational, though phase III results show impressive outcomes.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2 id=\"key-takeaways\">Key Takeaways<\/h2>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\">Retatrutide is not yet FDA-approved\u00a0and cannot be legally prescribed or obtained from a pharmacy.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Clinical trial participation is the only recommended access pathway\u00a0currently available. You can search for active trials on\u00a0<a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">ClinicalTrials.gov<\/a>.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Avoid illegal online sellers.\u00a0Products from these sources are dangerous and violate federal law.<\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\">Consult your healthcare provider\u00a0to discuss whether joining a clinical trial is appropriate for you or if an existing approved therapy is a better current option.<\/p>\n<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/getheally.com\/\">Heally<\/a> can connect you to a knowledgeable doctor who can help you find the best way forward. You don\u2019t have to navigate this alone; let\u2019s find the right solution together! Schedule your <a href=\"https:\/\/md.getheally.com\/f\/vshop-book_appt?visit_type_first=true&amp;utm_source=blog&amp;visit_type_ids=3070\">free consult<\/a>!<\/p>\n<h2 id=\"sources\">Sources<\/h2>\n<ul>\n<li>New England Journal of Medicine:\u00a0<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2301972\" target=\"_blank\" rel=\"noopener noreferrer\">Triple\u2013Hormone-Receptor Agonist Retatrutide for Obesity<\/a><\/li>\n<li>JAMA Network:\u00a0<a href=\"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2812930\" target=\"_blank\" rel=\"noopener noreferrer\">FDA Issues Warnings About Compounded Versions of Semaglutide and Tirzepatide<\/a><\/li>\n<li>U.S. Food and Drug Administration (FDA):\u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/public-health-focus\/expanded-access\" target=\"_blank\" rel=\"noopener noreferrer\">Expanded Access: Information for Patients<\/a><\/li>\n<li>U.S. Food and Drug Administration (FDA):\u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-warns-consumers-not-use-counterfeit-or-unapproved-versions-popular-weight-loss-and\" target=\"_blank\" rel=\"noopener noreferrer\">FDA In Brief: FDA Warns Consumers Not to Use Counterfeit or Unapproved Versions of Popular Weight Loss and Diabetes Drugs<\/a><\/li>\n<li>U.S. National Library of Medicine:\u00a0<a href=\"https:\/\/www.clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">Find a Clinical Trial: ClinicalTrials.gov<\/a><\/li>\n<li>Nature Reviews Endocrinology:\u00a0<a href=\"https:\/\/www.nature.com\/articles\/s41574-024-00970-4\" target=\"_blank\" rel=\"noopener noreferrer\">Next Generation of Incretin-Based Therapy for Obesity and Type 2 Diabetes<\/a><\/li>\n<li>The Lancet:\u00a0<a href=\"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(24)01182-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Efficacy and Safety of the GLP-1 and Glucagon Receptor Dual Agonist Survodutide for Metabolic Dysfunction-Associated Steatotic Liver Disease<\/a><\/li>\n<\/ul>\n<div class=\"grid-cols-1 grid gap-2.5 [&amp;_&gt;_*]:min-w-0\">\n<div class=\"p-rich_text_section\">Semaglutide FDA Labels:<\/div>\n<ol class=\"p-rich_text_list p-rich_text_list__ordered p-rich_text_list--nested\" data-stringify-type=\"ordered-list\" data-list-tree=\"true\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">FDA Label:\u00a0<a class=\"c-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/209637s025lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/209637s025lbl.pdf\" data-sk=\"tooltip_parent\">OZEMPIC (Semaglutide Injection) Medication Guide<\/a><\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">FDA Label:\u00a0<a class=\"c-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" data-sk=\"tooltip_parent\">WEGOVY (Semaglutide Injection) Medication Guide<\/a><\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">FDA Label:\u00a0<a class=\"c-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/213051s020s021lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/213051s020s021lbl.pdf\" data-sk=\"tooltip_parent\">RYBELSUS (Oral Semaglutide) Medication Guide<\/a><\/li>\n<\/ol>\n<div class=\"p-rich_text_section\">Tirzepatide FDA Labels:<\/div>\n<ol>\n<li>FDA Label:\u00a0<a class=\"c-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" data-sk=\"tooltip_parent\">MOUNJARO (Tirzepatide Injection) Medication Guide<\/a><\/li>\n<li>FDA Label:\u00a0<a class=\"c-link\" href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s015lbl.pdf\" data-sk=\"tooltip_parent\">ZEPBOUND (Tirzepatide Injection) Medication Guide<\/a><\/li>\n<\/ol>\n<div class=\"p-rich_text_section\">\n<h2 id=\"important-medical-information-and-disclaimers\" class=\"p-rich_text_section\">Important Medical Information and Disclaimers<\/h2>\n<p class=\"p-rich_text_section\">Medical Disclaimer<\/p>\n<p class=\"ds-markdown-paragraph\">This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis, treatment, and before starting any medication.<\/p>\n<p class=\"ds-markdown-paragraph\">Prescription GLP-1 medications like semaglutide (Ozempic\u00ae, Wegovy\u00ae, Rybelsus\u00ae) and tirzepatide (Mounjaro\u00ae, Zepbound\u00ae) are FDA-approved for specific uses and must be used under the supervision of a licensed healthcare provider. They are not over-the-counter supplements.<\/p>\n<h3 id=\"compounded-drug-warning\" class=\"p-rich_text_section\">Compounded Drug Warning<\/h3>\n<p class=\"p-rich_text_section\">The FDA has not approved compounded drugs and has issued safety alerts about dosing errors, product contamination, and other quality concerns. Compounded drugs are custom formulations made by pharmacies and may vary in quality, safety, and effectiveness, which can increase the risk of side effects or treatment failure. The FDA has warned against using these versions due to issues with incorrect ingredients, poor storage, or improper dosage. Always get medications from a licensed pharmacy with a valid prescription.<\/p>\n<h3 id=\"individual-results-may-vary\" class=\"p-rich_text_section\">Individual Results May Vary<\/h3>\n<p class=\"p-rich_text_section\">Responses to GLP-1 therapy can vary from person to person. Factors such as diet, physical activity, sleep quality, underlying medical conditions, other medications, and individual metabolism can all influence both side effects and overall results. Clinical trial outcomes may differ from real-world experiences.<\/p>\n<h5 id=\"possible-side-effects-of-glp-1-medications-may-include\" class=\"p-rich_text_section\">Possible Side Effects\u00a0of GLP-1 medications may include:<\/h5>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet p-rich_text_list--nested\" data-stringify-type=\"unordered-list\" data-list-tree=\"true\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Nausea<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Vomiting<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Diarrhea<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Constipation<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Stomach pain or discomfort<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Decreased appetite<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Indigestion or gas<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Redness, itching, or soreness at the injection site<\/li>\n<\/ul>\n<p class=\"p-rich_text_section\">Most side effects are mild to moderate and may improve as your body adjusts to treatment. If you experience severe or persistent symptoms, contact your healthcare provider promptly.<\/p>\n<h3 id=\"boxed-warning-thyroid-c-cell-tumor-risk\" class=\"p-rich_text_section\">Boxed Warning (Thyroid C-Cell Tumor Risk)<\/h3>\n<p class=\"p-rich_text_section\">GLP-1 receptor agonists, including semaglutide, carry an FDA boxed warning regarding the potential risk of thyroid C-cell tumors. Do not use if you or a family member has a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).<\/p>\n<h3 id=\"when-to-seek-immediate-medical-attention\" class=\"p-rich_text_section\">When to Seek Immediate Medical Attention<\/h3>\n<p class=\"p-rich_text_section\">Contact your healthcare provider or seek emergency care if you experience:<\/p>\n<ul class=\"p-rich_text_list p-rich_text_list__bullet p-rich_text_list--nested\" data-stringify-type=\"unordered-list\" data-list-tree=\"true\" data-indent=\"0\" data-border=\"0\">\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Severe abdominal pain that does not go away<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Signs of an allergic reaction (rash, swelling, difficulty breathing)<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Symptoms of pancreatitis (severe abdominal pain, vomiting)<\/li>\n<li data-stringify-indent=\"0\" data-stringify-border=\"0\">Symptoms of severe dehydration (dizziness, confusion, rapid heartbeat)<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<div class=\"grid-cols-1 grid gap-2.5 [&amp;_&gt;_*]:min-w-0\">\n<h3 id=\"fda-adverse-event-reporting\" class=\"p-rich_text_section\">FDA Adverse Event Reporting<\/h3>\n<div class=\"p-rich_text_section\">To report medication side effects to the FDA, visit <a class=\"c-link\" href=\"http:\/\/www.fda.gov\/medwatch\" target=\"_blank\" rel=\"noopener noreferrer\" data-stringify-link=\"http:\/\/www.fda.gov\/medwatch\" data-sk=\"tooltip_parent\">www.fda.gov\/medwatch<\/a> or call 1-800-FDA-1088. You may also contact the medication\u2019s manufacturer directly.<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"Retatrutide is a promising &#8220;triple agonist&#8221; weight loss medication that has shown impressive results in clinical trials. However,&hellip;\n","protected":false},"author":7,"featured_media":36349,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1794],"tags":[1860,2754,2278,1852,2755,2756,2757,2758,2760,2759,1793,1830,1765,1840],"class_list":{"0":"post-36355","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-weight-loss","8":"tag-glp-1","9":"tag-how-to-get-retatrutide-early","10":"tag-medication-comparison","11":"tag-retatrutide","12":"tag-retatrutide-access-2026","13":"tag-retatrutide-clinical-trials-sign-up","14":"tag-retatrutide-compassionate-use","15":"tag-retatrutide-early-access-program","16":"tag-retatrutide-patient-options","17":"tag-retatrutide-prescription-before-fda","18":"tag-semaglutide","19":"tag-tirzepatide","20":"tag-weight-loss","21":"tag-weight-loss-results"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Can You Access Retatrutide Before FDA Approval?<\/title>\n<meta name=\"description\" content=\"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Can You Access Retatrutide Before FDA Approval?\" \/>\n<meta property=\"og:description\" content=\"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\" \/>\n<meta property=\"og:site_name\" content=\"Heally\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/getheally.com\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-17T22:27:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-17T22:33:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Heally\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Heally\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#article\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\"},\"author\":{\"name\":\"Heally\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\"},\"headline\":\"How to Get Retatrutide in 2026: Understanding Your Options\",\"datePublished\":\"2025-12-17T22:27:19+00:00\",\"dateModified\":\"2025-12-17T22:33:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\"},\"wordCount\":1648,\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg\",\"keywords\":[\"glp-1\",\"how to get retatrutide early\",\"Medication Comparison\",\"retatrutide\",\"retatrutide access 2026\",\"retatrutide clinical trials sign up\",\"retatrutide compassionate use\",\"retatrutide early access program\",\"retatrutide patient options\",\"retatrutide prescription before FDA\",\"semaglutide\",\"tirzepatide\",\"weight loss\",\"Weight loss results\"],\"articleSection\":[\"Weight Loss\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\",\"url\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\",\"name\":\"Can You Access Retatrutide Before FDA Approval?\",\"isPartOf\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage\"},\"thumbnailUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg\",\"datePublished\":\"2025-12-17T22:27:19+00:00\",\"dateModified\":\"2025-12-17T22:33:07+00:00\",\"description\":\"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.\",\"breadcrumb\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage\",\"url\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg\",\"contentUrl\":\"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg\",\"width\":1000,\"height\":1000,\"caption\":\"Pharmacist counseling a woman at a pharmacy counter, representing discussions about access to investigational weight loss medications like retatrutide before FDA approval.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/getheally.com\/patients\/news\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to Get Retatrutide in 2026: Understanding Your Options\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#website\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"name\":\"Heally\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#organization\",\"name\":\"Heally\",\"url\":\"https:\/\/getheally.com\/patients\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"contentUrl\":\"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png\",\"width\":152,\"height\":52,\"caption\":\"Heally\"},\"image\":{\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/getheally.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea\",\"name\":\"Heally\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Can You Access Retatrutide Before FDA Approval?","description":"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options","og_locale":"en_US","og_type":"article","og_title":"Can You Access Retatrutide Before FDA Approval?","og_description":"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.","og_url":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options","og_site_name":"Heally","article_publisher":"https:\/\/getheally.com","article_published_time":"2025-12-17T22:27:19+00:00","article_modified_time":"2025-12-17T22:33:07+00:00","og_image":[{"width":1000,"height":1000,"url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg","type":"image\/jpeg"}],"author":"Heally","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Heally","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#article","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options"},"author":{"name":"Heally","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea"},"headline":"How to Get Retatrutide in 2026: Understanding Your Options","datePublished":"2025-12-17T22:27:19+00:00","dateModified":"2025-12-17T22:33:07+00:00","mainEntityOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options"},"wordCount":1648,"publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg","keywords":["glp-1","how to get retatrutide early","Medication Comparison","retatrutide","retatrutide access 2026","retatrutide clinical trials sign up","retatrutide compassionate use","retatrutide early access program","retatrutide patient options","retatrutide prescription before FDA","semaglutide","tirzepatide","weight loss","Weight loss results"],"articleSection":["Weight Loss"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options","url":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options","name":"Can You Access Retatrutide Before FDA Approval?","isPartOf":{"@id":"https:\/\/getheally.com\/patients\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage"},"thumbnailUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg","datePublished":"2025-12-17T22:27:19+00:00","dateModified":"2025-12-17T22:33:07+00:00","description":"Learn whether you can access retatrutide before FDA approval, including clinical trials, compassionate use limits, and legal safety risks.","breadcrumb":{"@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#primaryimage","url":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg","contentUrl":"https:\/\/getheally.com\/patients\/news\/wp-content\/uploads\/2025\/12\/how-to-get-retatrutide-in-2026-understanding-your-options.jpg","width":1000,"height":1000,"caption":"Pharmacist counseling a woman at a pharmacy counter, representing discussions about access to investigational weight loss medications like retatrutide before FDA approval."},{"@type":"BreadcrumbList","@id":"https:\/\/getheally.com\/patients\/news\/how-to-get-retatrutide-in-2026-understanding-your-options#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/getheally.com\/patients\/news"},{"@type":"ListItem","position":2,"name":"How to Get Retatrutide in 2026: Understanding Your Options"}]},{"@type":"WebSite","@id":"https:\/\/getheally.com\/patients\/news\/#website","url":"https:\/\/getheally.com\/patients\/news\/","name":"Heally","description":"","publisher":{"@id":"https:\/\/getheally.com\/patients\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/getheally.com\/patients\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/getheally.com\/patients\/news\/#organization","name":"Heally","url":"https:\/\/getheally.com\/patients\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/","url":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","contentUrl":"https:\/\/wpcdn.getheally.com\/patients\/wp-content\/uploads\/2019\/05\/12231047\/heallybl.png","width":152,"height":52,"caption":"Heally"},"image":{"@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/getheally.com"]},{"@type":"Person","@id":"https:\/\/getheally.com\/patients\/news\/#\/schema\/person\/af10deadfddea19cb3f5e0f3919632ea","name":"Heally"}]}},"_links":{"self":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/comments?post=36355"}],"version-history":[{"count":2,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36355\/revisions"}],"predecessor-version":[{"id":36358,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/posts\/36355\/revisions\/36358"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media\/36349"}],"wp:attachment":[{"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/media?parent=36355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/categories?post=36355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/getheally.com\/patients\/news\/wp-json\/wp\/v2\/tags?post=36355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}